# Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus

> **NCT03010683** · NA · COMPLETED · sponsor: **University of Athens** · enrollment: 60 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- Coronary Artery Disease

## Interventions

- **DRUG:** Liraglutide
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT03010683
- **Lead sponsor:** University of Athens
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2017-06
- **Final completion:** 2017-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03010683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03010683, "Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03010683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*